Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases.

Cosset E, Locatelli M, Marteyn A, Lescuyer P, Dall Antonia F, Mor FM, Preynat-Seauve O, Stoppini L, Tieng V.

J Vis Exp. 2019 Jun 28;(148). doi: 10.3791/59682.

PMID:
31305527
2.

Elimination of proliferating cells from CNS grafts using a Ki67 promoter-driven thymidine kinase.

Tieng V, Cherpin O, Gutzwiller E, Zambon AC, Delgado C, Salmon P, Dubois-Dauphin M, Krause KH.

Mol Ther Methods Clin Dev. 2016 Nov 30;6:16069. eCollection 2016.

3.

Human three-dimensional engineered neural tissue reveals cellular and molecular events following cytomegalovirus infection.

Cosset É, Martinez Y, Preynat-Seauve O, Lobrinus JA, Tapparel C, Cordey S, Peterson H, Petty TJ, Colaianna M, Tieng V, Tirefort D, Dinnyes A, Dubois-Dauphin M, Kaiser L, Krause KH.

Biomaterials. 2015;53:296-308. doi: 10.1016/j.biomaterials.2015.02.094. Epub 2015 Mar 17.

PMID:
25890728
4.

Interplay of TRIM28 and DNA methylation in controlling human endogenous retroelements.

Turelli P, Castro-Diaz N, Marzetta F, Kapopoulou A, Raclot C, Duc J, Tieng V, Quenneville S, Trono D.

Genome Res. 2014 Aug;24(8):1260-70. doi: 10.1101/gr.172833.114. Epub 2014 May 30.

5.

Engineering of midbrain organoids containing long-lived dopaminergic neurons.

Tieng V, Stoppini L, Villy S, Fathi M, Dubois-Dauphin M, Krause KH.

Stem Cells Dev. 2014 Jul 1;23(13):1535-47. doi: 10.1089/scd.2013.0442. Epub 2014 Apr 3.

PMID:
24576173
6.

CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.

Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat-Zucman S, Paul P, Gornet JM, Douay C, Ravet S, Tamouza R, Charron D, Lémann M, Mayer L, Toubert A.

Gastroenterology. 2007 Jun;132(7):2346-58. Epub 2007 Mar 16.

PMID:
17570210
7.

BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia.

Boissel N, Rea D, Tieng V, Dulphy N, Brun M, Cayuela JM, Rousselot P, Tamouza R, Le Bouteiller P, Mahon FX, Steinle A, Charron D, Dombret H, Toubert A.

J Immunol. 2006 Apr 15;176(8):5108-16.

8.

[Natural killer lymphocyte activation in response to stress].

Toubert A, Dulphy N, Tieng V, Tamouza R, Charron D.

Transfus Clin Biol. 2003 Jun;10(3):109-12. Review. French.

PMID:
12798842
9.
10.

Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA.

Tieng V, Le Bouguénec C, du Merle L, Bertheau P, Desreumaux P, Janin A, Charron D, Toubert A.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2977-82. Epub 2002 Feb 5.

11.

[Subtypes of the HLA-B27 molecule and association with spondylarthropathies].

Toubert A, Tieng V, Boisgérault F, Dulphy N, Tamouza R, Charron D.

Ann Med Interne (Paris). 1998 Apr;149(3):145-8. French.

PMID:
11490536
12.

Common intra-articular T cell expansions in patients with reactive arthritis: identical beta-chain junctional sequences and cytotoxicity toward HLA-B27.

Dulphy N, Peyrat MA, Tieng V, Douay C, Rabian C, Tamouza R, Laoussadi S, Berenbaum F, Chabot A, Bonneville M, Charron D, Toubert A.

J Immunol. 1999 Apr 1;162(7):3830-9.

13.

[HLA-B27 molecular subtypes and spondylarthropathies].

Tieng V, Charron D, Toubert A.

Pathol Biol (Paris). 1998 Dec;46(10):737-40. French.

PMID:
9922989
14.

Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity.

Khalil-Daher I, Boisgérault F, Feugeas JP, Tieng V, Toubert A, Charron D.

Eur J Immunol. 1998 Nov;28(11):3840-9.

15.

Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Boisgérault F, Mounier J, Tieng V, Stolzenberg MC, Khalil-Daher I, Schmid M, Sansonetti P, Charron D, Toubert A.

Infect Immun. 1998 Sep;66(9):4484-90.

16.

HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes.

Tieng V, Dulphy N, Boisgérault F, Tamouza R, Charron D, Toubert A.

Immunogenetics. 1997;47(1):103-5. No abstract available.

PMID:
9382929
17.

Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.

Boisgérault F, Tieng V, Stolzenberg MC, Dulphy N, Khalil I, Tamouza R, Charron D, Toubert A.

J Clin Invest. 1996 Dec 15;98(12):2764-70.

18.

Absence of picornavirus genome in pityriasis rosea.

Aractingi S, Morinet F, Mokni M, Tieng V, Flageul B, Fermand JP, Dubertret L.

Arch Dermatol Res. 1996 Dec;289(1):60-1. No abstract available.

PMID:
9017139
19.

Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy.

Boisgerault F, Khalil I, Tieng V, Connan F, Tabary T, Cohen JH, Choppin J, Charron D, Toubert A.

Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3466-70.

Supplemental Content

Support Center